JKJohn J. P. Kastelein

John J. P. Kastelein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John J. P. Kastelein has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Albert Wiegman

    2 shared publications
  • Michael Reuben Hayden

    Department of Medical Genetics, University of British Columbia

    2 shared publications
  • Christian Gerdes

    Department of Medicine and Cardiology, Åarhus University Hospital, Åarhus, The Netherlands

    1 shared publication
  • Eric de Groot

    1 shared publication
  • Ernest J Schaefer

    Lipid Metabolism Laboratory, US Department of Agriculture, Human Nutrition Research, Center on Aging at TUFTS, University, Boston, USA

    1 shared publication
  • Etelka Moll

    From the Department of Vascular Medicine, Academic Medical Centre, Amsterdam (M.E.W., E.M., M.D.T., P.J.L., J.C.D., J.J.P.K.) and Atherosclerosis Lipids Outpatient Clinics, Thorax Centre, University Hospital Groningen (J.J.v.D.), the Netherlands; and Centre for Molecular Medicine and Therapeutics, UBC, Vancouver, Canada (S.N.P., M.R.H.).

    1 shared publication

Latest Publications

  • Paraoxonase genotype and carotid intima???media thickness in children with familial hypercholesterolemia

    by Mark Roest, Jessica Rodenburg, Albert Wiegman, John J.P. Kastelein, Hieronymus A.M. Voorbij

    BACKGROUND: Paraoxonase (PON) 1 is a high-density lipoprotein-associated enzyme that may protect against cardiovascular disease. METHOD: We have studied the contribution of PON-1 and PON-2 single nucleotide polymorphisms (SNP; L55M, Q192R and T-107C, S311C) to the intima-media thickness of the common carotid artery in a population of children with classic familial hypercholesterolaemia. RESULTS: The L-variant of the L55M SNP was associated with increased common carotid artery intima-media thickness when compared with the M-variant (P value for trend 0.03). No significant relationship was observed between the other SNP and common carotid artery intima-media thickness. CONCLUSIONS: Our findings suggest that variation at the PON-1 locus contributes to early atherosclerosis in children with familial hypercholesterolaemi


  • Surrogate markers of atherosclerosis: impact of statins

    by John J.P. Kastelein, Albert Wiegman, Eric de Groot


  • A Frequent Mutation in the Lipoprotein Lipase Gene (D9N) Deteriorates the Biochemical and Clinical Phenotype of Familial Hypercholesterolemia

    by Marianne E. Wittekoek, Etelka Moll, Simon N. Pimstone, Mieke D. Trip, Peter J. Lansberg, Joep C. Defesche, Jasper J. van Doormaal, Michael R. Hayden, John J. P. Kastelein

    —The D9N substitution is a common mutation in the lipoprotein lipase (LPL) gene. This mutation has been associated with reduced levels of HDL cholesterol and elevated triglycerides (TG) in a wide variety of patients. We investigated the influence of this D9N mutation on lipid and lipoprotein levels and risk for cardiovascular disease (CVD) in patients with familial hypercholesterolemia (FH). A total of 2091 FH heterozygotes, all of Dutch extraction, were screened for the D9N mutation using standard polymerase chain reaction techniques, followed by specific enzyme digestion. A total of 94 FH subjects carrried the D9N mutation at a carrier frequency of 4.5%. Carriers of other common LPL mutations, such as the N291S and the S447X were excluded. Clinical data on 80 FH individuals carrying the D9N were available and were compared with a FH control group matched for age, sex, and body mass index (n=203). Analysis revealed significantly higher TG ( P =0.01) and lower HDL-cholesterol levels ( P =0.002). Dyslipidemia was more pronounced in D9N carriers with higher body mass index. Moreover, FH patients carrying this common LPL mutation were at higher risk for CVD, (odds ratio=2.8; 95% CI, 1.43 to 5.32; P =0.002). The common D9N LPL mutation leads to increased TG and decreased HDL plasma levels in patients with FH. These effects are most apparent in those FH heterozygotes with an increased body mass index. Furthermore, this mutation, present in 4.5% of Dutch FH heterozygotes, leads to increased risk for CVD.


  • Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women

    by John Jp Kastelein, Jose M Ordovas, Marianne E Wittekoek, Simon N Pimstone, Peter Wf Wilson, S Eric Gagné, Martin G Larson, Ernest J Schaefer, Jolanda Ma Boer, Christian Gerdes, et al.

    We assessed the effect of two common mutations in the lipoprotein lipase gene (LPL), D9N and N291S, which have been shown to modulate plasma lipids in a wide spectrum of patients.A total of 1 114 men and 1 144 women from the Framingham Offspring Study (FOS) were analyzed for these two LPL variants. Subsequently, the association with fasting plasma lipids and risk of coronary artery disease (CHD) was determined. We extended our study by calculating weighed means of lipids and lipoproteins in carriers and non‐carriers for these LPL mutations in patients with genetic dyslipidemias, CHD patients and healthy controls.In the FOS sample, the D9N and N291S alleles were associated with lower high‐density lipoprotein‐cholesterol (HDL‐C) (Δ=−0.07 mmol/l, p=0.03) and a trend towards increased triglycerides (Δ=0.25 mmol/l, p=0.07). In women, a trend towards the high triglyceride, low HDL‐C phenotype was evident (Δ=−0.02 mmol/l for HDL‐C and Δ=0.14 mmol/l for triglycerides, respectively). Cumulative analysis of other studies of male carriers of the D9N and N291S revealed higher levels of triglycerides (D291N; 2.60(1.85) mmol/l vs. 1.62(1.18) mmol/l: p<0.0001) (D9N; 1.94 (1.19) mmol/l vs. 1.74(1.17) mmol/l: p<0.001) and lower HDL‐C (N291S; 1.04(0.32) mmol/l vs. 1.15(0.28) mmol/l: p<0.0001) (D9N; 1.08(0.24) mmol/l vs. 1.16(0.28) mmol/l: p<0.0001). In females, results differed with higher TG levels (N291S; 1.70(0.99) mmol/l vs. 1.10(0.63) mmol/l: p<0.001) (D9N; 1.08(0.76) mmol/l vs. 0.96(0.51) mmol/l: p<0.01) and lower HDL‐C levels (N291S; 1.27(0.33) mmol/l vs. 1.51(0.32) mmol/l: p<0.0001); however, the HDL‐C levels for D9N carriers were similar to non‐carriers (D9N; 1.52(0.29) mmol/l vs. 1.53(0.35) mmol/l: p=0.83).Our data provide evidence that common variants of the LPL gene are significant modulators of lipid and lipoprotein levels in both men and women.